Labshake search
Citations for Tocris :
101 - 150 of 454 citations for Tumor necrosis factor receptor superfamily member 3 TNFRSF3 Human HEK293 His since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2023Quote: ... NMDA- and GABAA- receptors was carried out by using CNQX (10 μM, Tocris), AP-5 (40 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... the GABAA receptor antagonist gabazine (SR 95531 hydrobromide, Tocris, Wiesbaden-Nordenstadt, Germany, 5 μM) was bath-applied for 60 min after having recorded a minimum of 20 min stable baseline responses ...
-
bioRxiv - Neuroscience 2020Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Neuroscience 2022Quote: ... and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5; 50 μM, Tocris).
-
All-optical interrogation of a direction selective retinal circuit by holographic wave front shapingbioRxiv - Neuroscience 2019Quote: ... and the metabotropic glutamate receptor agonist LAP4 (20 μM, catalog no 0103, Tocris Bioscience). The retina was left to rest in the dark for ~ 30-45 min ...
-
bioRxiv - Neuroscience 2020Quote: ... we also added the glutamate receptor antagonists NBQX and CPP (both 10 µM, Tocris). For current-clamp recordings with putative muscarinic receptor-mediated currents ...
-
bioRxiv - Neuroscience 2022Quote: ... and L-2-amino-5-phosphonopentanoic acid (APV, an NMDA receptor blocker) from Tocris. APV ...
-
bioRxiv - Neuroscience 2023Quote: ... the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC ...
-
bioRxiv - Neuroscience 2024Quote: ... while block of GABAB receptors was performed by application of 25μM CGP 46381 (Tocris). The locations of each patched cell were logged and displayed in the Figures.
-
bioRxiv - Neuroscience 2021Quote: ... glutamate and GABA receptor blockers (10 μM NBQX, Tocris, UK, 1044; 5 μM CPP, Tocris, 0247 ...
-
bioRxiv - Neuroscience 2022Quote: ... We bath-applied the following drugs: picrotoxin (PTX) (GABAA receptor antagonist, 10µM, Tocris Bioscience, #1128) and strychnine hydrochloride (Strych ...
-
bioRxiv - Neuroscience 2019Quote: ... For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM; Tocris); the D2-like antagonists sulpiride (20 µM ...
-
bioRxiv - Neuroscience 2020Quote: Designer receptor-ligand clozapine-N-oxide (CNO, Tocris Bioscience; 4936, CAS No: 34233-69-7) was dissolved in 0.9 % saline solution at a concentration of 0.1 mg/ml and administered i.p ...
-
bioRxiv - Cell Biology 2023Quote: ... or 10 μM TGFB receptor inhibitors including SB525334 (Selleckchem S1476) and A83-01 (Tocris 2939) were prepared according to the supplier’s instructions ...
-
bioRxiv - Neuroscience 2023Quote: ... GABAA and glycinergic receptor-mediated synaptic transmission was blocked using 50 μM picrotoxin (Tocris Bioscience), which was prepared from a 100 mM stock solution containing DMSO (final DMSO concentration ...
-
bioRxiv - Genetics 2020Quote: ... in the presence of patterning factors SB431542 (Tocris, 1614, 10 µM), XAV939 (Stemgent ...
-
bioRxiv - Neuroscience 2020Quote: ... Substance P was manipulated by injecting the agonist of the NK-1 receptor Substance P (Tocris) to an estimated final concentration of 200 nM ...
-
bioRxiv - Neuroscience 2022Quote: ... to block ionotropic gamma-amino-butyric acid receptors (GABAARs) and 10 μM NBQX (1044, Tocris Biosciences) to inhibit α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) ...
-
bioRxiv - Neuroscience 2021Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2022Quote: ... we slowly infused 200 nl of the GABAA receptor agonist muscimol (Tocris; 2 μM in saline) into the target area using a micro-syringe pump (KD Scientific ...
-
bioRxiv - Neuroscience 2023Quote: ... was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2023Quote: ... were dissolved in HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Neuroscience 2023Quote: ... neural medium was additionally supplemented with retinoid X receptor agonist SR 11237 (100 nM; Tocris, 3411). From day 22 ...
-
bioRxiv - Animal Behavior and Cognition 2023Quote: ... As a positive control we used potent agonist of CB1 and CB2 receptors CP55,940 (Tocris, UK). All doses were selected based on our previously published experiments46,50 ...
-
bioRxiv - Bioengineering 2019Quote: ... at 2μM and at 4μM and by blocking the RyR receptors using Ryanodine (Tocris, cat no. 1329). at 10μM ...
-
bioRxiv - Neuroscience 2021Quote: ... IP3 receptors were blocked by bath application of 2-APB (100 µM, Tocris, Germany, micro-perfusion pump), 2-APB was applied at least 15 min prior t-LTP induction and was present throughout the recordings ...
-
bioRxiv - Neuroscience 2022Quote: ... To monitor acute changes in [Cl-]i we bath applied GABAA receptor agonist muscimol (Tocris, 10 μM) and imaged at lower resolution (every 2 minutes at a resolution of 4.1 pixels/μm (512×512 pixels ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid, a selective NMDA receptor antagonist, Tocris).
-
bioRxiv - Neuroscience 2023Quote: The AMPA receptor antagonist cyanquixaline (6-cyano-7-nitroquinoxaline-2,3-dione; CNQX disodium salt; #1045; Tocris Biosciences) or 6,7-Dinitroquinoxaline-2,3(1H,4H)-dione (DNQX disodium salt ...
-
bioRxiv - Pharmacology and Toxicology 2023Quote: ... [2-Amino-4-[3-(trifluoromethyl)phenyl]-3-thienyl] phenylmethanone (VCP 171; Tocris, 1018830-99-3), 5-[2-(5-nitro-2-furanyl)ethenyl]-2-furancarboxylic acid ...
-
bioRxiv - Cell Biology 2024Quote: ... bEnd.3 cells were treated with either 3-methyladenine (3-MA, #1292 Tocris, MN, USA) or rapamycin (Rapa ...
-
bioRxiv - Neuroscience 2021Quote: ... were dissolved in magnesium-free HEPES-aCSF in the presence of non-NMDA glutamate receptor blockers (CNQX, Tocris, 0190 ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Neuroscience 2021Quote: ... along with blockers of ionotropic glutamate receptor blockers (DNQX 10 μM and MK801 1 μM, Tocris, Bristol, UK). Wide-field fluorescence imaging of SBFI-AM-stained slices was performed using a digital live acquisition imaging system (Andor Solis version 4.30.30034.0 ...
-
bioRxiv - Neuroscience 2023Quote: ... Then a single bolus of the dopamine D2 receptor agonist sumanirole (30 μM, Tocris No.2773 Abingdon, UK) (52 ...
-
bioRxiv - Neuroscience 2024Quote: ... Mice subsequently received an intraperitoneal injection of 1 mg/kg of the D1 receptor antagonist SCH 23390 (Tocris) and were left undisturbed for 30 minutes at which time the tail-pinch procedure was repeated ...
-
bioRxiv - Biochemistry 2020Quote: ... human BDNF (2837, Tocris), PACAP-38 (4031157 ...
-
bioRxiv - Neuroscience 2022Quote: ... human ghrelin (Tocris, 1463), recombinant mouse leptin (Cedarlane Laboratories Ltd ...
-
bioRxiv - Developmental Biology 2021Quote: ... fibroblast growth factor 10 (FGF10, 100 ng/ml, Preprotech) and PGE2 (1 mM, Tocris). After 3 passages we treated organoids with X5050 (Calbiochem ...
-
bioRxiv - Neuroscience 2019Quote: ... To block NMDA receptors we used D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris, 10 μM final concentration). To block glycinergic inhibition ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Biophysics 2022Quote: ... 100 μM 2-APB blocking stretch-activated inositol triphosphate receptors (InsP3Rs) on the ER/nuclear membranes (Tocris Bioscience #1224), 100 μM CK-666 (Tocris Bioscience #3950 ...
-
bioRxiv - Neuroscience 2021Quote: ... In a subset of experiments the D1 receptor agonist (SKF81297; 20 mg/kg in saline; Tocris R&D systems), was injected intraperitoneally while recording cADDis photometry signals ...
-
bioRxiv - Neuroscience 2023Quote: ... 5 mM QX314 was added into the intracellular pipette solution while GABAA receptor antagonist picrotoxin (PTX, 50 μM, Tocris), GABAB receptor antagonist CGP55845 (3 μM ...
-
bioRxiv - Evolutionary Biology 2023Quote: ... 0.33 mM CaCl2, 0.33 mM MgSO4) containing Smoothened inhibitor (BMS-833923, Selleckchem) or Activin receptor type 1 inhibitor (LDN 193189, TOCRIS) in 10 cm plastic dishes from 32 hpf to 72 hpf ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70mV in presence of 20□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Neuroscience 2020Quote: ... the N3 media was further supplemented with two factors: SB-431542 (5 µM, Tocris, 1614) and LDN-193189 (100 nM ...
-
bioRxiv - Neuroscience 2020Quote: Current-clamp recordings were performed using an BVC-700A amplifier (Dagan, Minneapolis, USA) with standard ACSF solution at 34°C containing the GABAB-receptor blocker CGP55845 (1 µM, Tocris). Recording pipettes with a resistance of 3-5 MΩ were pulled with a DMZ universal electrode puller (Zeitz-Instruments Vertriebs-GmbH ...
-
bioRxiv - Neuroscience 2021Quote: ... Glutamatergic neurons were identified by their characteristic EPSC time course and by sensitivity of EPSC to application of glutamate receptor antagonist kynurenic acid (Tocris). Synaptic currents were acquired at 10 kHz using pClamp 10.2 software (Molecular Devices ...
-
bioRxiv - Neuroscience 2021Quote: ... In some experiments fast synaptic transmission was blocked with continuous bath-application of the AMPA receptor blocker DNQX (25 μM; Tocris), the NMDA receptor blocker D-AP5 (25 μM ...